Medical/Pharmaceuticals

Global Cord Blood Corporation Appoints Mr. Siu Chuen Cheng as Independent Non-executive Director

HONG KONG, Feb. 6, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of Mr.Siu Chuen Chen...

2020-02-06 19:30 7063

Global Cord Blood Corporation Appoints Mr. Siu Chuen Cheng as Independent Non-executive Director

HONG KONG, Feb. 6, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of Mr.Siu Chuen Chen...

2020-02-06 19:30 12680

French Biotech TargEDys® Announces Positive Results of Its Clinical Trial With Its Probiotic Strain Hafnia alvei HA4597™ on the Weight Loss Thanks to Regulation of Appetite

PARIS, Feb. 6, 2020 /PRNewswire/ -- TargEDys® announces the successful completion of its 3 months, randomized, double blind, placebo-controlled, multicentric clinical study carried out on 229 subjects and evaluating the efficacy ofHafnia alvei HA4597™ in the weight loss by regulation of the appe...

2020-02-06 09:07 2372

Breakthrough Study Makes Cancer Detection Possible With a Simple Blood Test; Introduces a New Systemic Hallmark of Cancer

MUMBAI, India, Feb. 6, 2020 /PRNewswire/ -- A new study  by scientists from India, USA, and UK has presented clinical evidence for an innovative test that can detect clusters of cancer cells in the blood of asymptomatic individuals as a...

2020-02-06 08:00 2370

Proya donates over 90,000 EU standards-compliant face masks purchased from Europe to frontline medical staff in China's Hubei

HANGZHOU, China, Feb. 5, 2020 /PRNewswire/ -- More than 110,000 face masks, purchased from European countries by cosmetics maker Proya, were delivered to frontline medical staff inChina's Hubei province on February 4. Accompanied by Proya executives, the face masks, including some 90,000 European...

2020-02-05 21:11 3470

Year-end Report 2019 Bactiguard Holding AB

STOCKHOLM, Feb. 5, 2020 /PRNewswire/ -- A strong development in fourth quarter earnings, combined with the licensing deal with Zimmer Biomet led to the highest full-year result in Bactiguard's history. The financial effects of both increased BIP sales and new license revenues clearly show that ou...

2020-02-05 15:39 11576

Bridge Biotherapeutics Acquires a New Drug Development Candidate for Back-Eye Diseases

* Signed a collaboration and license agreement for developing back-eye disease treatments with Konkuk University in the Republic of Korea * A total of 10B KRW deal includes 300M KRW of upfront payment SEONGNAM, South Korea, Feb. 5, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical ...

2020-02-05 13:21 1154

Christian Kinch Resigns as CEO of Bactiguard and is Proposed as New Chairman of the Board. Cecilia Edström Appointed New CEO

STOCKHOLM, Sweden, Feb. 5, 2020 /PRNewswire/ -- Christian Kinch today announced to the Board that he will resign as CEO of Bactiguard Holding AB (publ) after close to 16 years. The Board has appointed CFO and Deputy CEOCecilia Edström as new CEO of Bactiguard andStefan Grass (CMO) as Deputy CEO. ...

2020-02-05 06:38 11256

United Imaging Sends Out More than 100 CT Scanners and X-Ray Machines to Aid Diagnosis of the Coronavirus

HOUSTON, Feb. 4, 2020 /PRNewswire/ -- United Imaging employees across the globe extend our thoughts and condolences to those affected by the coronavirus. To help front-line physicians, nurses, and other healthcare professionals diagnose and treat the coronavirus, United Imaging has donated medica...

2020-02-04 21:00 1487

Kungl. Vetenskapsakademien: Sjöberg Prize Awarded for Decisive Discoveries About Cell Growth

MALMO, Sweden, Feb. 4, 2020 /PRNewswire/ -- The Royal Swedish Academy of Sciences has decided to award the Sjöberg Prize 2020 ofone million US dollars to Michael Hall andDavid Sabatini. The two researchers have radically changed ideas about cell growth, an important factor in the development of c...

2020-02-04 14:52 929

Bactiguard Makes its First Acquisition by Acquiring Vigilenz

STOCKHOLM, Feb. 4, 2020 /PRNewswire/ -- Bactiguard deepens the partnership that was initiated in 2015 by acquiring Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz) in Malaysia. The acquisition strengthens Bactiguard's position in infection control and wound management, a...

2020-02-04 14:34 11522

Samsung Biologics Reports 64% Jump in FY19 Earnings, Sees Global Expansion in 2020

INCHEON, South Korea, Feb. 4, 2020 /PRNewswire/ -- Samsung Biologics, a pharmaceutical Contract Manufacturing Organization (CMO), recorded high for the fiscal year 2019, reporting 30.9% growth in sales at701.6 billion won, and 64.6% growth in operating profit at91.7 billion won compared to the ...

2020-02-04 13:50 1055

Pharmacy Alliance members come together in support of bushfire affected pharmacies & communities

SYDNEY, Feb. 4, 2020 /PRNewswire/ -- Pharmacy Alliance has established a bushfire appeal, aiming to raise$250,000 to support bushfire affected pharmacies in providing free medication and personal care items to their communities. Helen Feng...

2020-02-04 08:15 1783

China Jo-Jo Drugstores Steps in to Help Combat the 2019 Novel Coronavirus

HANGZHOU, China, Feb. 3, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services inChina, today an...

2020-02-04 06:00 7934

Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases

SEATTLE, Feb. 4, 2020 /PRNewswire/ -- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals and Trefoil Therapeutics announce the execution of a manufacturing contract to supply their lead compound TTHX1114.  Trefoil is developing products based...

2020-02-04 06:00 1881

Inovio Publishes Patient Benefit Results From A Pilot Clinical Study in Recurrent Respiratory Papillomatosis (RRP), A Rare Disease Caused by HPV Infections

PLYMOUTH MEETING, Pennsylvania, Feb. 3, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced publication of data from its pilot clinical study of INO-3106, a novel DNA therapy targeting human papilloma virus type 6 (HPV 6) for the treatment of recurrent respiratory pap...

2020-02-03 21:00 2440

Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target Therapies

Increased acceptance of outsourcing clinical trials predicted to propel sector revenues to$71.7 billion by 2024 SANTA CLARA, Calif., Feb. 3, 2020 /PRNewswire/ -- With an overall R&D expenditure of$167 billion in 2018, the global healthcare industry is investing heavily in the development of nove...

2020-02-03 17:01 1480

GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the treatment of relapsed or refractory multiple myeloma

- Belantamab mafodotin accepted for accelerated assessment by the EMA's Committee for Human Medicinal Products (CHMP) - Submission based on data from the pivotal DREAMM-2 study of immunoconjugate targeting B-cell maturation antigen (BCMA) recently published inThe Lancet Oncology LONDON, Feb. 3,...

2020-02-03 17:00 9186

Oxford Nanopore Sequencers Have Left UK for China, to Support Rapid, Near-sample Coronavirus Sequencing for Outbreak Surveillance

OXFORD, England, Feb. 3, 2020 /PRNewswire/ -- Following extensive support of, and collaboration with, public health professionals inChina, Oxford Nanopore has shipped an additional 200 MinION sequencers and related consumables toChina . These will be used to support the ongoing surveillance of the...

2020-02-03 05:20 2654

Coronavirus (2019-nCoV): The Facts

Collaboration Leads the Way to Better Understanding of Pathogen   SAN FRANCISCO, Feb.1, 2020 /PRNewswire/ -- Author: Barry Bunin, PhD, CEO of Collaborative Drug Discovery, Inc. Originally published on  https://www.collaborativedrug.com/coronavirus-2019-ncov-facts/ As news about the Wuhan Corona...

2020-02-01 07:30 2660
1 ... 595596597598599600601 ... 610

Week's Top Stories